The Department of Defense (DOD) offers this Tuberous Sclerosis Complex (TSC) Idea Development Award for innovative research. This grant aims to understand TSC pathogenesis and translate findings into patient care, ultimately decreasing TSC’s clinical impact. It supports high-impact, original studies that significantly advance the field by challenging paradigms or offering new perspectives. Preclinical studies are encouraged; clinical trials are not allowed. Only truly innovative research, not incremental advances, will be considered. Applicants must provide relevant preliminary data. Collaborative research between basic/clinical scientists and academic/industry partners is strongly encouraged.
Opportunity ID: 90414
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-11-TSCRP-IDA |
Funding Opportunity Title: | DOD Tuberous Sclerosis Complex Idea Development Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 28, 2011 |
Last Updated Date: | – |
Original Closing Date for Applications: | Aug 01, 2011 |
Current Closing Date for Applications: | Aug 01, 2011 |
Archive Date: | Aug 31, 2011 |
Estimated Total Program Funding: | $2,700,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The Tuberous Sclerosis Complex Research Program (TSCRP) was established in 2002 to promote innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC). The mission of the TSCRP is to encourage innovative research aimed at understanding the pathogenesis of TSC and to translate these findings to the care of individuals with TSC. The FY11 TSCRP Idea Development Award supports high-impact, innovative research that will drive the field of TSC research forward. Preclinical studies are encouraged but clinical trials are not allowed. Important aspects of the Idea Development Award are as follows: The proposed research should have a significant impact on the concepts or methods that drive the field of TSC research. The proposed research is expected to make an important and original contribution to advancing TSC research and/or patient care. Research deemed innovative may represent a new paradigm, challenge existing paradigms, or look at existing problems from new perspectives or exhibit other uniquely creative qualities. Research may be innovative in study concept, research methods or technology, clinical interventions, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not considered innovative. Preliminary data should be included that is relevant to the proposed project. The FY11 TSCRP strongly supports collaborative research between basic scientists and clinical researchers, and between academic scientists and biotechnology/pharmaceutical industry scientists. Collaborations that bring new perspectives from other disciplines or bring new investigators into the TSC field are also strongly encouraged. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-682-5507; help@cdmrp.org
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:help@cdmrp.org |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 90414 Full Announcement-1 -> tscrp_fy11 ida pa_gg.pdf
Packages
Agency Contact Information: | PA HELP: 301-682-5507; help@cdmrp.org eReceipt HELP: 301-682-5507; help@cdmrp.org Email: help@cdmrp.org |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00050612 | Apr 28, 2011 | Aug 01, 2011 | View |
Package 1
Mandatory forms
90414 RR_SF424_1_2-1.2.pdf
90414 PerformanceSite_1_4-1.4.pdf
90414 RR_Budget-1.1.pdf
90414 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
90414 RR_SubawardBudget30-1.2.pdf